Skip to main content
Contact Us
Subscribe
E-Edition
88°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
G1 Therapeutics Inc
(NQ:
GTHX
)
3.670
+0.040 (+1.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about G1 Therapeutics Inc
< Previous
1
2
3
4
Next >
G1 Therapeutics Stock: The Undervalued Gem Poised for a 30% Revenue Surge by 2025
July 15, 2024
While there’s no denying that G1 Therapeutics stock is highly speculative, investors should still check under the hood.
Via
InvestorPlace
Biotech Bombshell: G1 Therapeutics Stock Is Too Much of a Gamble
July 10, 2024
G1 Therapeutics stock is highly volatile, and investors should be wary now as G1 Therapeutics recently failed to achieve a clinical goal.
Via
InvestorPlace
Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday
June 25, 2024
Via
Benzinga
Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears
June 24, 2024
A 2024 coffee recall is in effect for products made by Snapchill LLC due to concerns of botulism from the FDA for hundreds of canned coffees.
Via
InvestorPlace
Exposures
Product Safety
Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts
June 24, 2024
Ginkgo Bioworks layoffs are a hot topic as the company prepares to cut 158 jobs this week with more headcount reductions coming next week.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Analyst Ratings For G1 Therapeutics
June 13, 2024
Via
Benzinga
Evaluating G1 Therapeutics: Insights From 5 Financial Analysts
May 01, 2024
Via
Benzinga
Breaking Down G1 Therapeutics: 5 Analysts Share Their Views
April 12, 2024
Via
Benzinga
Forecasting The Future: 5 Analyst Projections For G1 Therapeutics
February 28, 2024
Via
Benzinga
Alnylam's Closely Watched Phase 3 Heart Disease Trial Of Vutrisiran Hits Primary Endpoint, Shares Surge
June 24, 2024
Alnylam Pharmaceuticals reports positive results from the HELIOS-B Phase 3 study of vutrisiran for ATTR amyloidosis with cardiomyopathy. The trial showed significant reductions in mortality and...
Via
Benzinga
Why Is Cancer-Focused G1 Therapeutics Stock Trading Lower On Monday?
June 24, 2024
Shares of G1 Therapeutics are down after release of Phase 3 trial results for trilaciclib in TNBC.
Via
Benzinga
Why Is G1 Therapeutics (GTHX) Stock Down 56% Today?
June 24, 2024
G1 Therapeutics stock is down on Monday as GTHX investors react to the company's Phase 3 clinical trial of trilaciclib failing.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 24, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news on Monday morning!
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
June 11, 2024
Via
Benzinga
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 28, 2024
Via
Benzinga
What's Going On With G1 Therapeutics Stock?
May 09, 2024
According to a report, G1 Therapeutics has received and rejected multiple offers from TerSera Therapeutics. According to the report, one offer from TerSera is rumored to have a contingent value right...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 09, 2024
Via
Benzinga
GTHX Stock Earnings: G1 Therapeutics Beats EPS, Misses Revenue for Q1 2024
May 01, 2024
GTHX stock results show that G1 Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 28, 2024
Via
Benzinga
Why Is Breast Cancer-Focused G1 Therapeutics Stock Trading Lower Today?
February 13, 2024
Follow G1 Therapeutics as it advances trilaciclib in Phase 3 PRESERVE 2 trial for metastatic triple-negative breast cancer. Updates on trial progress, interim analysis, and potential FDA filing in...
Via
Benzinga
Exposures
Product Safety
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 13, 2024
Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 13, 2024
Via
Benzinga
Evercore ISI Is Warming Up to NextEra Energy (NEE) Stock
February 13, 2024
NextEra Energy stock is on the move Tuesday after Evercore ISI initiated coverage of NEE shares with a bull rating and price target.
Via
InvestorPlace
UBS Just Upped Its Nvidia (NVDA) Stock Price Target
February 13, 2024
Nvidia stock is a hot topic among NVDA traders on Tuesday after the company's shares got a new $850 price target from UBS analysts.
Via
InvestorPlace
Why ZoomInfo Technologies Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
February 13, 2024
Shares of ZoomInfo Technologies Inc. (NASDAQ: ZI) rose sharply in today’s pre-market trading as the company reported stronger-than-expected fourth-quarter financial results.
Via
Benzinga
Why Is Polished.com (POL) Stock Down 33% Today?
February 13, 2024
Polished.com stock is sliding lower on Tuesday as investors in POL react to the company missing a debt payment and other dangers.
Via
InvestorPlace
Why Is G1 Therapeutics (GTHX) Stock Down 45% Today?
February 13, 2024
G1 Therapeutics stock is down on Tuesday after the company provided GTHX investors with an update on a Phase 3 clinical trial.
Via
InvestorPlace
ZoomInfo Technologies To Rally Around 50%? Here Are 10 Top Analyst Forecasts For Tuesday
February 13, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.